Python venom traces could waste antivenom

April 16, 2013

A University of Queensland researcher has found the potential for Australian doctors to prescribe expensive antivenom to snake bite victims who don't need it.

UQ School of Biological Sciences Associate Professor Bryan Grieg Fry and colleagues have published research this week which shows are a surprising potential source of false-positives in detection kits.

Associate Professor Fry said that although pythons were non-venomous, "relic" traces of venom in their could trigger the extremely sensitive snake venom detection kits.

"Using antivenom to treat patients with python bite injuries could potentially trigger life-threatening allergies to the antivenom, without the benefit of curing a snake bite," he said.

"Unnecessary use of the antivenom reduces stocks available for patients who actually need it."

Associate Professor Fry said this highlighted the decisions about administering antivenom should be based on the severity of clinical symptoms.

"A venom detection kit should be used to ensure that the appropriate is given, but it is sometimes mistakenly used as a diagnosis of by itself," he said.

"All snakes evolved from a that was a venomous lizard."

"Evolution is like a crime scene, there is always evidence to be found if the scientist is a good enough detective."

Associate Professor Fry said snakes had varying potency of 'venomosity' ranging from those capable of life-threatening bites, such as or taipans, to those that have lost almost all their venom, such as egg-eating and pythons.

Previous studies that found python saliva could cross-react in the snake venom detection kit were dismissed as an anomaly.

Associate Professor Fry's study found that a python's oral glands predominantly secrete mucous to aid in swallowing large prey, but there are also traces of relic venom.

"The extremely low levels of toxins in their mouths have no effect on prey or bitten humans, however in forensic-level diagnostic tools like the snake venom detection kit, they cross-react and give a false positive."

"These novel molecules represent an untapped resource for biodiscovery," Associate Professor Fry said.

"We have found that the low level of ancient toxins still secreted in these glands includes novel compounds quite different than those from their well-studied cousins like rattlesnakes or mambas."

"In addition to providing insights regarding how the snake venom system evolved, these results reinforce the value of studying a wide range of snakes, as novel compounds with significant potential for use in drug design and development may be uncovered in the most unlikely of places," he said.

The study findings are published in Molecular & Cellular Proteomics.

Explore further: New species of sea snake discovered

Related Stories

New species of sea snake discovered

February 21, 2012
(PhysOrg.com) -- Scientists have discovered a new species of sea snake in the Gulf of Carpenteria, northern Australia, which is unique in having raised scales.

Insight into snake venom evolution could aid drug discovery

September 19, 2012
UK-led scientists have made a discovery about snake venom that could lead to the development of new drugs to treat a range of life-threatening conditions like cancer, diabetes and high blood pressure.

Mamba venom holds promise for pain relief

October 3, 2012
Scientists have used the venom of Africa's lethal black mamba to produce a surprising outcome in mice which they hope to replicate in humans—effective pain relief without toxic side effects.

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.